Publications by authors named "Michael Fridrik"

32Publications

ASCO update on lymphoma.

Memo 2017 24;10(4):218-219. Epub 2017 Nov 24.

Department of Internal Medicine 3, Centre for Hematology and Medical Oncology, Kepler University Hospital, Krankenhausstraße 9, 4021 Linz, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12254-017-0372-yDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5725511PMC
November 2017

Oxaliplatin/Irinotecan/Bevacizumab Followed by Docetaxel/Bevacizumab in Inoperable Locally Advanced or Metastatic Gastric Cancer Patients - AGMT_GASTRIC-3.

Anticancer Res 2017 10;37(10):5553-5558

IIIrd Medical Department at the Paracelsus Medical University Salzburg, Salzburg Cancer Research Institute (SCRI), Cancer Cluster Salzburg (CCS), Salzburg, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.21873/anticanres.11987DOI Listing
October 2017

Treatment of Patients With Myelodysplastic Syndrome With Lenalidomide in Clinical Routine in Austria.

Clin Lymphoma Myeloma Leuk 2015 Nov 5;15(11):e143-9. Epub 2015 Aug 5.

Internal Medicine I, Medical Oncology, Hematology and Gastroenterology, Bamherzige Schwestern Hospital, Linz, Austria. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clml.2015.07.645DOI Listing
November 2015

Lapatinib-plus-pegylated liposomal doxorubicin in advanced HER2-positive breast cancer following trastuzumab: a phase II trial.

Anticancer Res 2015 Jan;35(1):517-21

3rd Medical Department with Haematology, Medical Oncology, Hemostaseology, Infectious Diseases, Rheumatology, Oncologic Centre, Salzburg Cancer Research Institute (SCRI) with the Laboratory of Immunological and Molecular Cancer Research (SCRI-LIMCR) and the Center for Clinical Cancer and Immunology Trials (SCRI-CCCIT), Paracelsus Medical University Salzburg, Salzburg, Austria

View Article

Download full-text PDF

Source
January 2015

A phase 1 dose escalation study of BI 831266, an inhibitor of Aurora kinase B, in patients with advanced solid tumors.

Invest New Drugs 2015 Apr 23;33(2):409-22. Epub 2014 Dec 23.

Ludwig Boltzmann Institute for Applied Cancer Research (LBI-ACR VIEnna) - LB Cluster Translational Oncology and Applied Cancer Research-Institution for Translational Research Vienna (ACR-ITR VIEnna), Third Medical Department, Center for Oncology and Hematology, Kaiser-Franz-Josef-Spital, Vienna, Austria,

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10637-014-0201-7DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4387274PMC
April 2015

Experience with lenalidomide in an Austrian non-study population with advanced myelofibrosis.

Wien Klin Wochenschr 2013 Apr 28;125(7-8):196-9. Epub 2013 Mar 28.

Innere Medizin IV, Klinikum Wels-Grieskirchen, Grieskirchnerstraße 42, 4600 Wels, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00508-013-0345-zDOI Listing
April 2013

Rituximab plus subcutaneous cladribine in patients with extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue: a phase II study by the Arbeitsgemeinschaft Medikamentose Tumortherapie.

Haematologica 2013 Feb 14;98(2):264-8. Epub 2012 Sep 14.

Department of Internal Medicine III with Hematology, Medical Oncology, Hemostaseology, Infectious Diseases, Rheumatology, Oncologic Center, Paracelsus Medical University Salzburg, Austiria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3324/haematol.2012.072587DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3561434PMC
February 2013

First annual report of the Austrian CML registry.

Wien Klin Wochenschr 2010 Oct 11;122(19-20):558-66. Epub 2010 Oct 11.

Department of Internal Medicine V, Haematology & Oncology, Innsbruck Medical University, Innsbruck, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00508-010-1450-xDOI Listing
October 2010

Dose-dense therapy improves survival in aggressive non-Hodgkin's lymphoma.

Ann Hematol 2010 Mar 20;89(3):273-82. Epub 2009 Aug 20.

Department Internal Medicine 3, Centre for Hematology and Medical Oncology, General Hospital Linz, Krankenhausstrasse 9, 4020, Linz, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00277-009-0811-xDOI Listing
March 2010

Multicenter phase II study of pegylated liposomal doxorubicin in combination with vinorelbine as first-line treatment in elderly patients with metastatic breast cancer.

Onkologie 2009 Feb 20;32(1-2):18-24. Epub 2009 Jan 20.

Paracelsus Medical University Salzburg, 3rd Medical Department with Hematology, Medical Oncology, Hemostaseology, Rheumatology and Infectious Disease and Laboratory of Immunological and Molecular Cancer Research, Müllner Hauptstrasse 48, Salzburg, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000180915DOI Listing
February 2009

Sentinel node mapping performed before preoperative chemotherapy may avoid axillary dissection in breast cancer patients with negative or micrometastatic sentinel nodes.

Am J Surg 2008 Aug 29;196(2):176-83. Epub 2008 May 29.

Second Department of Surgery, Ludwig Boltzmann Institute for Surgical Endoscopy, AKH Linz, Krankenhausstrasse 9, 4020 Linz, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.amjsurg.2007.08.068DOI Listing
August 2008

Exemestane as primary systemic treatment for hormone receptor positive post-menopausal breast cancer patients: a phase II trial of the Austrian Breast and Colorectal Cancer Study Group (ABCSG-17).

Breast Cancer Res Treat 2008 Nov 22;112(1):203-13. Epub 2007 Dec 22.

IIIrd Medical Department with Hematology, Medical Oncology, Hemostaseology, Rheumatology and Infectious Disease, Laboratory of Immunological and Molecular Cancer Research, Paracelsus Medical University Salzburg, Salzburg, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-007-9843-xDOI Listing
November 2008

Is the statistical difference clinically relevant?

J Clin Oncol 2005 Nov;23(33):8537; author reply 8537-8

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2005.03.6525DOI Listing
November 2005

Three-dimensional ultrasound to assess the response to treatment in gynecological malignancies.

Gynecol Oncol 2005 May;97(2):665-8

Department of Obstetrics and Gynecology, General Hospital of Linz, Krankenhausstrasse 9, A-4020 Linz, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ygyno.2005.01.012DOI Listing
May 2005

Sentinel node biopsy performed before preoperative chemotherapy for axillary lymph node staging in breast cancer.

Breast J 2003 Jul-Aug;9(4):282-7

Second Department of Surgery-Ludwig Boltzmann Institute, Allgemein Offentliches Krankenhaus, Linz, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1046/j.1524-4741.2003.09406.xDOI Listing
November 2003